Acrotech Biopharma LLC   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: East Windsor NJ United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04184869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Acrotech Biopharma | Acrotech BioPharmaceuticals, Inc. | Acrotech Biopharma Inc. | Acrotech Biopharma LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Breast Neoplasms (Phase 1)

Hematologic Diseases (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Neoplasms (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 11